First OTC cannabis by early 2023?

Wellnex Life hoping for SAS OK by year’s end with S3 approval to follow in next quarter - and a market potentially worth "billions" ASX-listed health and wellness outfit Wellnex is aiming to be the first company to produce and market an over-the-counter cannabis preparation, ramping up its efforts for S3 approval for a market